Clinical Trials Browser

Phase 1/2 × Advanced Solid Tumor × conteltinib × Clear all

NCT06970132 2025-05-14

Study of SY-5933 Plus CT-707 in Advanced Solid Tumors With KRAS p.G12C Mutation

Phase 1/2 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumor